Class IITerminatedVoluntary: Firm initiated
A New Life Herbs, LLC: food recall H-0343-2026
A New Life Herbs, LLC of Somerville, TN recalled Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory… Reason: Unapproved drug claims on product labeling and product misbranded due to no Supplement Facts label. The FDA listed it as Class II in its Enforcement Report dated Dec 31, 2025; distribution: Alabama, Arizona, California, Georgia, Illinois, Indiana, Minnesota, Missouri, Mississippi, North Carolina, New York, Tennessee.
Record status as published: Terminated (terminated Aug 28, 2026). openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory properties, useful for pain & inflammation; packaged in a 2 oz. glass dropper bottle, UPC 284260392420
- Product quantity
- 278 bottles
- Reason for recall
- Unapproved drug claims on product labeling and product misbranded due to no Supplement Facts label
- Codes, lots and dates on the package
- T848B EXP 11/30 T836B EXP 10/30 T808B EXP 9/30 T771B EXP 7/30 T723B EXP 3/30 T696B EXP 1/29 T655B EXP 10/29 T594B EXP 4/29 T536B EXP 10/28
- Distribution pattern
- AL, AZ, CA, GA, IL, IN, MN, MO, MS, NC, NY, TN
- Recalling firm
- A New Life Herbs, LLC, Somerville, TN
- Classification
- Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Nov 20, 2025 |
| Classified by the FDA | Dec 23, 2025 |
| Published in the Enforcement Report | Dec 31, 2025 |
| Terminated | Aug 28, 2026 |
Other products in the same recall event
The FDA groups related products under one recall event (event 98037).
- H-0348-2026 — Sinus Cap Herbal Supplement, Herbs containing antibiotic, drying, expectorant, and emollient properties, Fenugreek, Thyme, Oregon Grape Root, & Bentonite Clay, 50 capsules/510 mg; packaged in a plastic bag
- H-0347-2026 — Pain Away Herbal Supplement, Analgesic & anti-inflammatory properties, Wood Betony & White Willow in vegetable glycerin, packaged in a 4.5 oz. glass bottle or 9 oz. glass bottle, UPC 231946534537
- H-0346-2026 — Organic Ginger Root Herbal Supplement, Natural anti-inflammatory properties, supports gut, increases circulation, 50 capsules/560 mg, packaged in a plastic bag
- H-0345-2026 — Ear Drops Herbal Supplement, Mullein flower alcohol tincture 1:5, Pain relieving and antibiotic properties, packaged in a 0.5 oz. plastic dropper bottle
- H-0344-2026 — Chaga Mushroom Herbal Supplement, 1:5 Alcohol Double Extract, Supports a healthy immune system with anti-cancer properties; packaged in a 2 oz. glass dropper bottle, UPC 284588087831
- H-0342-2026 — Baby Soothe Herbal Supplement, Promotes rest, helps ease colic, upset stomach, and teething discomfort, Contains: Catnip, Chamomile, Vegetable Glycerin, water; packaged in a 2 oz. glass dropper bottle
- H-0341-2026 — Baby Allergy Herbal Supplement, Contains: Echinacea Purpurea, Oregon Grape Root, Dandelion & Burdock Root, Fenugreek, Ginger Root in vegetable glycerin; packaged in a 2 oz. glass dropper bottle, UPC 249953949282
- H-0340-2026 — Anti-virus Herbal Supplement, 1:5 Alcohol Tincture, Helps to stop viral replication, expectorant properties, Contains: Forsethia blossoms, Sumac berries, Pine needles; packaged in a 2 oz. glass dropper bottle, UPC…
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0343-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.